Colour theme
Theme
Sign in
Insider · CIK 0001886431

Fitzgerald Kevin Joseph

CIK 0001886431 Name as filed on the most recent filing

Filed as Fitzgerald Kevin Joseph (13)

152 transaction lines · from 13 filings · filed 2024-06-26 to 2026-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

152 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-03-05 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 233 disposed 323.25 75,317.25 Form 4, filing 0001735276-26-000059
2026-03-05 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 153 disposed 326.24 49,914.72 Form 4, filing 0001735276-26-000059
2026-03-05 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 148 disposed 324.60 48,040.80 Form 4, filing 0001735276-26-000059
2026-03-05 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 124 disposed 321.81 39,904.44 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 210 disposed 323.84 68,006.40 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 96 disposed 323.01 31,008.96 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 79 disposed 321.82 25,423.78 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 75 disposed 324.88 24,366.00 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 59 disposed 320.81 18,927.79 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 57 disposed 325.67 18,563.19 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 29 disposed 319.03 9,251.87 Form 4, filing 0001735276-26-000059
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 28 disposed 320.01 8,960.28 Form 4, filing 0001735276-26-000059
2026-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 722 disposed 320.51 231,408.22 Form 4, filing 0001735276-26-000051
2026-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 359 disposed 321.58 115,447.22 Form 4, filing 0001735276-26-000051
2026-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 289 disposed 316.55 91,482.95 Form 4, filing 0001735276-26-000051
2026-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 282 disposed 318.62 89,850.84 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 392 disposed 326.81 128,109.52 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 329 disposed 327.67 107,803.43 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 258 disposed 325.63 84,012.54 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 170 disposed 329.71 56,050.70 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 100 disposed 328.71 32,871.00 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 94 disposed 331.93 31,201.42 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 90 disposed 324.65 29,218.50 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 81 disposed 330.85 26,798.85 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 47 disposed 323.62 15,210.14 Form 4, filing 0001735276-26-000051
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 37 disposed 332.64 12,307.68 Form 4, filing 0001735276-26-000051
2026-02-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 2,041 disposed 331.96 677,531.58 Form 4, filing 0001735276-26-000026
2026-02-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,959 disposed 310.08 607,448.29 Form 4, filing 0001735276-26-000026
2026-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 644 disposed 370.00 238,280.00 Form 4, filing 0001735276-26-000011
2026-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 562 disposed 368.76 207,243.12 Form 4, filing 0001735276-26-000011
2026-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 485 disposed 371.24 180,051.40 Form 4, filing 0001735276-26-000011
2026-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 280 disposed 372.93 104,420.40 Form 4, filing 0001735276-26-000011
2026-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 197 disposed 367.52 72,401.44 Form 4, filing 0001735276-26-000011
2026-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 122 disposed 374.33 45,668.26 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 220 disposed 365.56 80,423.20 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 199 disposed 364.83 72,601.17 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 155 disposed 360.22 55,834.10 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 123 disposed 358.18 44,056.14 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 98 disposed 361.45 35,422.10 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 96 disposed 357.17 34,288.32 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 92 disposed 368.62 33,913.04 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 85 disposed 359.14 30,526.90 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 73 disposed 362.38 26,453.74 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 50 disposed 366.41 18,320.50 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 47 disposed 363.55 17,086.85 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 42 disposed 355.16 14,916.72 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 41 disposed 367.40 15,063.40 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 41 disposed 356.09 14,599.69 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 40 disposed 369.48 14,779.20 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 39 disposed 353.95 13,804.05 Form 4, filing 0001735276-26-000011

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 152
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Fitzgerald Kevin Joseph, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001886431

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.